1-3 of 3
Andre C. Schuh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation

Harry J Iland, Nigel H. Russell, Richard Dillon, Andre C. Schuh, Aditya Tedjaseputra, Andrew H. Wei, Asim Khwaja, Steven Knapper, Steven W Lane, John Reynolds, Mary Frances Frances McMullin, Annalise Maria Martin, Peter Tan, David Christopher C Taussig, Anny Wong, John M Taper, Christina Fraga, Richard Kelly, Kiran Tawana, Priyanka Mehta, Alain Mina, Jessica K. Altman, Ingolf Mølle, Sudhir Tauro, Eleni Tholouli
Journal: Blood Advances
Blood Adv bloodadvances.2022007126.
DOI: https://doi.org/10.1182/bloodadvances.2022007126
Published: 2022
Includes: Supplemental data
Journal Articles

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML

Tracy Murphy, Jinfeng Zou, Georgina S. Daher-Reyes, Andrea Arruda, Vikas Gupta, Caroline J. McNamara, Mark D. Minden, Aaron D. Schimmer, Hassan Sibai, Karen W. L. Yee, Mariam Korulla, Tracy Stockley, Suzanne Kamel-Reid, Dawn Maze, Anne Tierens, Scott V. Bratman, Andre C. Schuh, Steven M. Chan
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2307–2311.
DOI: https://doi.org/10.1182/bloodadvances.2019000306
Published: 2019
Includes: Supplemental data
Journal Articles

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia

Clinical Trials & Observations
Anthony S. Stein, Richard A. Larson, Andre C. Schuh, William Stevenson, Ewa Lech-Maranda, Qui Tran, Zachary Zimmerman, William Kormany, Max S. Topp
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1522–1531.
DOI: https://doi.org/10.1182/bloodadvances.2018019034
Published: 2018
Includes: Supplemental data